Cerebrospinal Fluid Lactic Dehydrogenase Activity in Children with Acute Lymphoblastic Leukemia Treated for Cranial Prophylaxis

Main Article Content

Musa Kazim Caglar
Gonul Hicsonmez
Nurten Renda

Abstract

Total lactic dehydrogenase (TLDH) activity in cerebrospinal fluid (CSF) has been prospectively studied in order to determine whether it could be a biochemical marker for brain damage due to cranial prophylaxis in children with acute lymphob/atic leukemia (ALL). TLDH activity has been measured in 15 patients before prophylaxis, in 15 patients after the prophylaxis which consisted of cranial radiotherapy (2400 rads) and intrathecal methotrexate (0.5 mg/kg-dose, 5 doses), in 8 patients after radiotherapy alone (2400 rads) and in 9 patients after intrathecal methotrexate (0.5 mg!kg-dose, 5 doses) alone. TLDH activity in CSF of combined prophylaxis group has been found to be higher than the ones before study (p < 0.05). There were insignificant elevations of TLDH activity in the other two groups (p > 0.05; p > 0.05). This result indicated combined cranial prophylaxis seemed to be more toxic than the other prophylaxis regimens when they were used alone.

Article Details

How to Cite
1.
Caglar M, Hicsonmez G, Renda N. Cerebrospinal Fluid Lactic Dehydrogenase Activity in Children with Acute Lymphoblastic Leukemia Treated for Cranial Prophylaxis. PI [Internet]. 20Mar.2018 [cited 21Jul.2019];29(5-6):112-. Available from: https://paediatricaindonesiana.org/index.php/paediatrica-indonesiana/article/view/1864
Section
Articles
Author Biography

Nurten Renda, Hacettepe Children's Hospital and Department of Biochemistry of Hacettape University, Ankara

)

Received 2018-05-14
Published 2018-03-20

References

1. ElSER, G.: Intellectual abilities among survivors of childhood leukemia as a function of CNS irradiation. Arch . Dis. Child. 53 : 391 (1978).
2. GANJI, D.; REAMAN, G.H.; COHEN, S.R., et al.: Leukoencephalopathy and elevated levels of myelin basic protein in the cerebrospinal fluid of patients with acute lymphoblastic leukemia. New Engl. J . Med. 303 : I9 (1980).
3. GOLDBERG, F.; WEINER, L.B. : Cerebrospinal fluid white blood cell count and lactic dehydrogenasein enterovirus type 7I meningitis. Clin. Pediat. 20 : 327 (I98I).
4. GOLDBERG,I.D.; BLOOMER, W.O.; DAWSON, D.M.: Nervous system toxic effects of cancer therapy. 1. Am. Med. Ass. 247 : 1437 (1982).
5. HALL, R.T.; KULKARNI, P.B.; SHEEHAN M.B., et al.: Cerebrospinal fluid lactate dehydrogenase in infants with perinatal asphyxia. Devl. Med. Child Neur. 22 : 300 (I980).
6. HALLOCK,J.A.; DEVOE, P.; KOHN, B., et al.: Clinical implications of LDH in cerebrospinal fluid. Clin. Pediat. 17 : 372 (1978).
7. HICSONMEZ, G.; CAGLAR, K.; RENDA, N. : Serum lactic dehydrogenase isoenzyme patterns in childhood lymphoblastic leukemia. Blood 68 : 322 (I986).
8. TIETZ, N.: Fundamentals of clinical chemistry. pp. 575, 657-658 (Saunders, Philadelphia I976).
9. KOLLMANNSKOF, S.; MOE, P.J.; ANKE, I.M .: Computed tomographic findings of brain in children with ALL after CNS prophylaxis without cranial irradiation . Acta paediat. scand. 68 : 875 (1979) .
10. LADDY, R.E.; GILMAN, P.A.: Paraplegia following intrathecal methotrexate, J. Pediat. 83 : 988 (1973).
11. LENDING, M.; SLOBODY, L.B.; STONE; M.L.: Activity of LDH in CSF and plasma in normal and abnormal newborn infants. Pediatrics 24 : 378 (1959).
12. MOTT, M.G.; STEVENSON, P .; WOOD, C.B.: Methotrexate meningitis. Lancet ii : 656 (1972).
13. NELSON, P.V.; CAREY, W.F.; POLLARD, A.C. : Diagnostic significance and source of LDH and its isoenzymes in CSF of children with a variety of neurological disorders. J . clin. Path. 28 : 828 (1975)
14. PEDERSEN, H.; CLAUSEN, N. : The development of cerebral CT changes during treatment of ALL in childhood. Neuroradiology 22 : 79 (I98I).
15 . WELLS, R.C.; FOSTER, M.B.; DERCOLE, 1.: The impact of cranial irradiation on the growth of children with ALL. Am. 1. Dis. Child. 137 : 37 (1983).
16. WILCOCK, A.R.; SHARPE, D.M.; GOLDBERG, D.M.:-Kinetic similarity of enzymes in human blood, serum and cerebrospinal fluid. J. neurol. Sci. 20 : 97 (I973).
17. WROBLEWSKI, F.; DECKER, B.; WROBLEWSKI, R.: Activity of lactic dehydrogenase in spinal fluid. Am. 1. Clin. Path. 28 : 269 (1957).
18. WROBLEWSKI, F.; DECKER, B.; WROBLEWSKI, R.: The clinical implications of spinal fluid LDH activity. New Engl. J. Med. 258 : 635 (1958).